As i see it...
10 plus years of human experience with tissue treated eith the ADAPT technogy with no reported calcification associated adverse outcomes.....implanted in thousands of patients.
other companies on tbe verge of using Cardiocel for a valve implanted in a human...
bench study showing Catdiolcel material valves perform no worse than alternate existing matetial... and suggested thst cc is superior for longevity.
AHZ petforming their own animal studies with human studies planned.
all tbe planets seem to be aligning........
Why Admedus’ shift to aortic valve replacement is good news for patients under 65, page-14
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |